speb/financial-data huggingface dataset:
IBS.LS income_statement (quarterly, 2025-03-31) — Special Income Charges: -86169.00
IBS.LS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 336935188.00
IBS.LS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 237977414.00
IBS.LS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -18744.36
IBS.LS income_statement (quarterly, 2025-03-31) — Tax Provision: -981897.00
IBS.LS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.22
IBS.LS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 3126545.00
IBS.LS cash_flow (quarterly, 2025-03-31) — Taxes Refund Paid Direct: -85358.00
IBS.LS balance_sheet (quarterly, 2025-03-31) — Total Assets: 735670360.00
IBS.LS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 358886730.00
IBS.LS balance_sheet (quarterly, 2025-03-31) — Total Debt: 312506070.00
IBS.LS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 336925643.00
IBS.LS income_statement (quarterly, 2025-03-31) — Total Expenses: 116140733.00
IBS.LS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 398744717.00
IBS.LS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 550211554.00
IBS.LS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 229056415.00
IBS.LS income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -645805.00
IBS.LS income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: 119265.00
IBS.LS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 201388.00
IBS.LS income_statement (quarterly, 2025-03-31) — Total Unusual Items: -86169.00
IBS.LS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -86169.00
IBS.LS balance_sheet (quarterly, 2025-03-31) — Tradeand Other Payables Non Current: 3704.00
IBS.LS balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 581532.00
IBS.LS balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 4417043.00
IBS.LS balance_sheet (quarterly, 2025-03-31) — Working Capital: 15770503.00
IBS.LS income_statement (quarterly, 2025-03-31) — Write Off: 9000.00
IBS.LS income_statement (quarterly, 2025-06-30) — +Operating Expense: 52495034.00
IBS.LS income_statement (quarterly, 2025-06-30) — +Total Revenue: 130959705.00
IBS.LS balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 55292641.00
IBS.LS balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 6893118.00
IBS.LS balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -402630992.00
IBS.LS balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 29900789.00
IBS.LS balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -2830870.00
IBS.LS balance_sheet (quarterly, 2025-06-30) — Assets Held For Sale Current: 0.00
IBS.LS cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 134173390.00
IBS.LS balance_sheet (quarterly, 2025-06-30) — Buildings And Improvements: 616802557.00
IBS.LS balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 267722681.00
IBS.LS balance_sheet (quarterly, 2025-06-30) — Capital Stock: 41514818.00
IBS.LS balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 120090423.00
IBS.LS balance_sheet (quarterly, 2025-06-30) — Cash Equivalents: 119133173.00
IBS.LS cash_flow (quarterly, 2025-06-30) — Changes In Cash: -8531119.00
IBS.LS cash_flow (quarterly, 2025-06-30) — Classesof Cash Receiptsfrom Operating Activities: 132680743.00
IBS.LS cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -2505363.00
IBS.LS balance_sheet (quarterly, 2025-06-30) — Construction In Progress: 2474026.00
IBS.LS balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 73053103.00
IBS.LS balance_sheet (quarterly, 2025-06-30) — Current Debt: 11235047.00
IBS.LS balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 84288150.00
IBS.LS balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 173691336.00
IBS.LS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 25201904.00
IBS.LS income_statement (quarterly, 2025-06-30) — EBIT: 7894804.00
IBS.LS cash_flow (quarterly, 2025-06-30) — End Cash Position: 119726652.00
IBS.LS cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 43135899.00
IBS.LS balance_sheet (quarterly, 2025-06-30) — Goodwill: 58587677.00
IBS.LS balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 9723988.00
IBS.LS balance_sheet (quarterly, 2025-06-30) — Gross PPE: 801576719.00
IBS.LS income_statement (quarterly, 2025-06-30) — Gross Profit: 60637405.00
IBS.LS balance_sheet (quarterly, 2025-06-30) — Held To Maturity Securities: 875793.00
IBS.LS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 4303175.00
IBS.LS income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 760976.00
IBS.LS cash_flow (quarterly, 2025-06-30) — Interest Received Cfi: 743906.00
IBS.LS balance_sheet (quarterly, 2025-06-30) — Inventory: 15962137.00
IBS.LS balance_sheet (quarterly, 2025-06-30) — Invested Capital: 344084601.00
IBS.LS cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -19101095.00
IBS.LS balance_sheet (quarterly, 2025-06-30) — Investment Properties: 12388904.00
IBS.LS balance_sheet (quarterly, 2025-06-30) — Land And Improvements: 9982257.00
IBS.LS balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 194669578.00
IBS.LS cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: -1764026.00
IBS.LS cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -1774696.00
IBS.LS balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 5441002.00
IBS.LS balance_sheet (quarterly, 2025-06-30) — Minority Interest: -20943.00
IBS.LS income_statement (quarterly, 2025-06-30) — Minority Interests: 11398.00
IBS.LS cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -2505363.00
IBS.LS income_statement (quarterly, 2025-06-30) — Net Income: 5120873.00
IBS.LS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 5120873.00
IBS.LS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 5120873.00
IBS.LS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 5109475.00
IBS.LS cash_flow (quarterly, 2025-06-30) — Net Intangibles Purchase And Sale: -2141678.00
IBS.LS income_statement (quarterly, 2025-06-30) — Net Interest Income: -3723435.00
IBS.LS cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 311258.00
IBS.LS cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -3538722.00
IBS.LS cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 0.00
IBS.LS balance_sheet (quarterly, 2025-06-30) — Net PPE: 398945727.00
IBS.LS cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -18014581.00
IBS.LS balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 211264082.00
IBS.LS balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 10115591.00
IBS.LS balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 2607325.00
IBS.LS income_statement (quarterly, 2025-06-30) — Normalized Income: 5383388.20
IBS.LS income_statement (quarterly, 2025-06-30) — Operating Revenue: 130959705.00
IBS.LS balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 40668635.00
IBS.LS cash_flow (quarterly, 2025-06-30) — Other Cash Adjustment Outside Changein Cash: -5562340.00
IBS.LS cash_flow (quarterly, 2025-06-30) — Other Cash Paymentsfrom Operating Activities: 10391654.00
IBS.LS balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 40395998.00
IBS.LS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 29733655.00
IBS.LS balance_sheet (quarterly, 2025-06-30) — Other Properties: 172317879.00
IBS.LS balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 363771.00
IBS.LS income_statement (quarterly, 2025-06-30) — Other Special Charges: 313144.00
IBS.LS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
IBS.LS balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 2477526.00
IBS.LS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 25201904.00
IBS.LS cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -1774696.00
IBS.LS balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 260721904.00
IBS.LS cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 0.00
IBS.LS income_statement (quarterly, 2025-06-30) — Special Income Charges: -328144.00
IBS.LS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -65628.80
IBS.LS income_statement (quarterly, 2025-06-30) — Tax Provision: -1517845.00
IBS.LS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.20
IBS.LS balance_sheet (quarterly, 2025-06-30) — Total Assets: 703990264.00
IBS.LS balance_sheet (quarterly, 2025-06-30) — Total Debt: 301559525.00
IBS.LS balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 310226814.00
IBS.LS income_statement (quarterly, 2025-06-30) — Total Expenses: 122817334.00
IBS.LS income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 7361267.00
IBS.LS income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: 181236.00
IBS.LS balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 96271.00
IBS.LS income_statement (quarterly, 2025-06-30) — Total Unusual Items: -328144.00
IBS.LS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -328144.00
IBS.LS income_statement (quarterly, 2025-09-30) — +Operating Expense: 56192141.00
IBS.LS income_statement (quarterly, 2025-09-30) — +Total Revenue: 148069809.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 51983278.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 7038278.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -419614065.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 29900789.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -2868035.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Assets Held For Sale Current: 0.00
IBS.LS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 30625682.00
IBS.LS income_statement (quarterly, 2025-09-30) — Basic EPS: 0.33
IBS.LS cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 119726652.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Buildings And Improvements: 620519725.00
IBS.LS cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -7705028.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 260496988.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 40899126.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 127367647.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 127730583.00
IBS.LS cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: 0.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Cash Equivalents: 126757259.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Cash Financial: 610388.00
IBS.LS cash_flow (quarterly, 2025-09-30) — Cash Flowsfromusedin Operating Activities Direct: 43772373.00
IBS.LS cash_flow (quarterly, 2025-09-30) — Changes In Cash: 7646932.00
IBS.LS cash_flow (quarterly, 2025-09-30) — Classesof Cash Payments: -107291667.00
IBS.LS cash_flow (quarterly, 2025-09-30) — Classesof Cash Receiptsfrom Operating Activities: 148955145.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Common Stock: 40899126.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 317314774.00
IBS.LS cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -2974454.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 5531205.00
IBS.LS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 75211807.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Current Assets: 171460629.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 71884212.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Current Debt: 5764203.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 77648415.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Current Deferred Assets: 2037098.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 168224742.00
IBS.LS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 26032031.00
IBS.LS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 26032031.00
IBS.LS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 40425900.00
IBS.LS income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.25
IBS.LS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 10106475.00
IBS.LS income_statement (quarterly, 2025-09-30) — EBIT: 17127112.00
IBS.LS income_statement (quarterly, 2025-09-30) — EBITDA: 43159143.00
IBS.LS cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -5937.00
IBS.LS cash_flow (quarterly, 2025-09-30) — End Cash Position: 127367647.00
IBS.LS cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -28796539.00
IBS.LS cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 36067345.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Goodwill: 58587677.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 98081082.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 9906313.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 810080576.00
IBS.LS income_statement (quarterly, 2025-09-30) — Gross Profit: 72858002.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Held To Maturity Securities: 873652.00
IBS.LS income_statement (quarterly, 2025-09-30) — Interest Expense: 4104495.00
IBS.LS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 4104495.00
IBS.LS income_statement (quarterly, 2025-09-30) — Interest Income: 481426.00
IBS.LS income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 481426.00
IBS.LS cash_flow (quarterly, 2025-09-30) — Interest Paid Cff: -51007731.00
IBS.LS cash_flow (quarterly, 2025-09-30) — Interest Received Cfi: 436578.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Inventory: 17049313.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 344408008.00
IBS.LS cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -7328902.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Investment Properties: 12313763.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 873652.00
IBS.LS cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: -2067949.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Land And Improvements: 9979056.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 188612776.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 21329031.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 209941807.00
IBS.LS cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: -2067949.00
IBS.LS cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -4486651.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 5420827.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 189709.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Minority Interest: -37286.00
IBS.LS income_statement (quarterly, 2025-09-30) — Minority Interests: 16343.00
IBS.LS cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -2974454.00
IBS.LS income_statement (quarterly, 2025-09-30) — Net Income: 10106475.00
IBS.LS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 10106475.00
IBS.LS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 10090132.00
IBS.LS income_statement (quarterly, 2025-09-30) — Net Income Discontinuous Operations: 0.00
IBS.LS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 10106475.00
IBS.LS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 10106475.00
IBS.LS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 10090132.00
IBS.LS cash_flow (quarterly, 2025-09-30) — Net Intangibles Purchase And Sale: -379862.00
IBS.LS income_statement (quarterly, 2025-09-30) — Net Interest Income: -3623069.00
IBS.LS cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -60452.00
IBS.LS cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -6554600.00
IBS.LS cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -6554600.00
IBS.LS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -3623069.00
IBS.LS cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 0.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Net PPE: 390466511.00
IBS.LS cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -7325166.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 219233692.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 10064234.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 3765533.00
IBS.LS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 43159143.00
IBS.LS income_statement (quarterly, 2025-09-30) — Normalized Income: 10106475.00
IBS.LS income_statement (quarterly, 2025-09-30) — Operating Income: 16665861.00
IBS.LS income_statement (quarterly, 2025-09-30) — Operating Revenue: 148069809.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 40366030.00
IBS.LS cash_flow (quarterly, 2025-09-30) — Other Cash Adjustment Outside Changein Cash: 0.00
IBS.LS cash_flow (quarterly, 2025-09-30) — Other Cash Paymentsfrom Operating Activities: -5486641.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 39493405.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 2.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 1.00
IBS.LS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 32045197.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Other Payable: 15871916.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Other Properties: 174050590.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 15295877.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 362936.00
IBS.LS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Payables: 68445709.00
IBS.LS cash_flow (quarterly, 2025-09-30) — Paymentson Behalfof Employees: -40354379.00
IBS.LS cash_flow (quarterly, 2025-09-30) — Paymentsto Suppliersfor Goodsand Services: -61450647.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 2220346.00
IBS.LS income_statement (quarterly, 2025-09-30) — Pretax Income: 13022617.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
IBS.LS cash_flow (quarterly, 2025-09-30) — Purchase Of Intangibles: -379862.00
IBS.LS cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -7325166.00
IBS.LS cash_flow (quarterly, 2025-09-30) — Receiptsfrom Customers: 148955145.00
IBS.LS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 75211807.00
IBS.LS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 26032031.00
IBS.LS cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -4486651.00
IBS.LS cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -2974454.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 266725321.00
IBS.LS cash_flow (quarterly, 2025-09-30) — Sale Of Investment: -29379.00
IBS.LS cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 0.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Share Issued: 40899126.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 317314774.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 219233692.00
IBS.LS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
IBS.LS income_statement (quarterly, 2025-09-30) — Tax Provision: 2932485.00
IBS.LS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.23
IBS.LS balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 89134.00
IBS.LS cash_flow (quarterly, 2025-09-30) — Taxes Refund Paid Direct: 2108895.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Total Assets: 699402984.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 338643805.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Total Debt: 287590222.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 317277488.00
IBS.LS income_statement (quarterly, 2025-09-30) — Total Expenses: 131403948.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 382125496.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 527942356.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 213900754.00
IBS.LS income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 16665861.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 590515.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Tradeand Other Payables Non Current: 3704.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 533096.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 5178110.00
IBS.LS balance_sheet (quarterly, 2025-09-30) — Working Capital: 3235887.00
IBS.LS income_statement (annual, 2025-12-31) — +Operating Expense: 226604896.00
IBS.LS income_statement (quarterly, 2025-12-31) — +Operating Expense: 67217469.00
IBS.LS income_statement (annual, 2025-12-31) — +Total Revenue: 529515952.00
IBS.LS income_statement (quarterly, 2025-12-31) — +Total Revenue: 134724043.00
IBS.LS balance_sheet (annual, 2025-12-31) — Accounts Payable: 46708249.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 46708249.00
IBS.LS balance_sheet (annual, 2025-12-31) — Accounts Receivable: 6593440.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 6593440.00
IBS.LS balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -442311692.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -442311692.00
IBS.LS balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 29900789.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 29900789.00
IBS.LS balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -2321563.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -2321563.00
IBS.LS balance_sheet (annual, 2025-12-31) — Assets Held For Sale Current: 0.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Assets Held For Sale Current: 0.00
IBS.LS balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 1024255.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 1024255.00
IBS.LS income_statement (annual, 2025-12-31) — Basic Average Shares: 40640543.00
IBS.LS income_statement (annual, 2025-12-31) — Basic EPS: 0.37
IBS.LS cash_flow (annual, 2025-12-31) — Beginning Cash Position: 140659284.00
IBS.LS cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 127367647.00
IBS.LS balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 643867009.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 643867009.00
IBS.LS cash_flow (annual, 2025-12-31) — Capital Expenditure: -36451786.00
IBS.LS cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -8590499.00
IBS.LS balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 262377324.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 262377324.00
IBS.LS balance_sheet (annual, 2025-12-31) — Capital Stock: 40899126.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Capital Stock: 40899126.00
IBS.LS balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 117543920.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 117543920.00
IBS.LS balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 117872202.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 117872202.00
IBS.LS cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -28539062.00
IBS.LS cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: 0.00
IBS.LS cash_flow (annual, 2025-12-31) — Cash Flowsfromusedin Operating Activities Direct: 126957083.00
IBS.LS cash_flow (quarterly, 2025-12-31) — Cash Flowsfromusedin Operating Activities Direct: 23304891.00
IBS.LS cash_flow (annual, 2025-12-31) — Changes In Cash: -20438051.00
IBS.LS cash_flow (quarterly, 2025-12-31) — Changes In Cash: -7505631.00
IBS.LS cash_flow (annual, 2025-12-31) — Classesof Cash Payments: -405410589.00
IBS.LS cash_flow (quarterly, 2025-12-31) — Classesof Cash Payments: -110770972.00
IBS.LS cash_flow (annual, 2025-12-31) — Classesof Cash Receiptsfrom Operating Activities: 531155419.00
IBS.LS cash_flow (quarterly, 2025-12-31) — Classesof Cash Receiptsfrom Operating Activities: 134668380.00
IBS.LS balance_sheet (annual, 2025-12-31) — Common Stock: 40899126.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Common Stock: 40899126.00
IBS.LS balance_sheet (annual, 2025-12-31) — Common Stock Equity: 316999439.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 316999439.00
IBS.LS cash_flow (annual, 2025-12-31) — Common Stock Payments: -10701715.00
IBS.LS cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -3501567.00
IBS.LS balance_sheet (annual, 2025-12-31) — Construction In Progress: 1462112.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 1462112.00
IBS.LS income_statement (annual, 2025-12-31) — Cost Of Revenue: 272083068.00
IBS.LS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 61215342.00
IBS.LS balance_sheet (annual, 2025-12-31) — Current Assets: 163492213.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Current Assets: 163492213.00
IBS.LS balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 67376570.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 67376570.00
IBS.LS balance_sheet (annual, 2025-12-31) — Current Debt: 5664536.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Current Debt: 5664536.00
IBS.LS balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 73041106.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 73041106.00
IBS.LS balance_sheet (annual, 2025-12-31) — Current Deferred Assets: 1992686.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Current Deferred Assets: 1992686.00
IBS.LS balance_sheet (annual, 2025-12-31) — Current Liabilities: 153888077.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 153888077.00
IBS.LS income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 102752781.00
IBS.LS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 26392521.00
IBS.LS income_statement (annual, 2025-12-31) — Depreciation Income Statement: 102752781.00
IBS.LS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 26392521.00
IBS.LS income_statement (annual, 2025-12-31) — Diluted Average Shares: 40640543.00
IBS.LS income_statement (annual, 2025-12-31) — Diluted EPS: 0.37
IBS.LS income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 15206452.00
IBS.LS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 3499389.00
IBS.LS income_statement (annual, 2025-12-31) — EBIT: 31821503.00
IBS.LS income_statement (quarterly, 2025-12-31) — EBIT: 7051909.00
IBS.LS income_statement (annual, 2025-12-31) — EBITDA: 134574284.00
IBS.LS income_statement (quarterly, 2025-12-31) — EBITDA: 33444430.00
IBS.LS cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -362185.00
IBS.LS cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -2969.00
IBS.LS cash_flow (annual, 2025-12-31) — End Cash Position: 119859048.00
IBS.LS cash_flow (quarterly, 2025-12-31) — End Cash Position: 119859048.00
IBS.LS cash_flow (annual, 2025-12-31) — Financing Cash Flow: -120924129.00
IBS.LS cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -23236140.00
IBS.LS balance_sheet (annual, 2025-12-31) — Finished Goods: 852173.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Finished Goods: 852173.00
IBS.LS cash_flow (annual, 2025-12-31) — Free Cash Flow: 90505297.00
IBS.LS cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 14714392.00
IBS.LS income_statement (annual, 2025-12-31) — General And Administrative Expense: 7542965.00
IBS.LS balance_sheet (annual, 2025-12-31) — Goodwill: 58587677.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Goodwill: 58587677.00
IBS.LS balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 96293723.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 96293723.00
IBS.LS balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 8915003.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 8915003.00
IBS.LS balance_sheet (annual, 2025-12-31) — Gross PPE: 833048120.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Gross PPE: 833048120.00
IBS.LS income_statement (annual, 2025-12-31) — Gross Profit: 257432884.00
IBS.LS income_statement (quarterly, 2025-12-31) — Gross Profit: 73508701.00
IBS.LS income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 133244.00
IBS.LS income_statement (annual, 2025-12-31) — Interest Expense: 17025436.00
IBS.LS income_statement (quarterly, 2025-12-31) — Interest Expense: 4356247.00
IBS.LS income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 17025436.00
IBS.LS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 4356247.00
IBS.LS income_statement (annual, 2025-12-31) — Interest Income: 2605080.00
IBS.LS income_statement (quarterly, 2025-12-31) — Interest Income: 796078.00
IBS.LS income_statement (annual, 2025-12-31) — Interest Income Non Operating: 2605080.00
IBS.LS income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 796078.00
IBS.LS cash_flow (annual, 2025-12-31) — Interest Paid Cff: -17661141.00
IBS.LS cash_flow (quarterly, 2025-12-31) — Interest Paid Cff: 42458861.00
IBS.LS cash_flow (annual, 2025-12-31) — Interest Received Cfi: 2936283.00
IBS.LS cash_flow (quarterly, 2025-12-31) — Interest Received Cfi: 1018459.00
IBS.LS balance_sheet (annual, 2025-12-31) — Inventories Adjustments Allowances: -74981.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Inventories Adjustments Allowances: -74981.00
IBS.LS balance_sheet (annual, 2025-12-31) — Inventory: 16704441.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Inventory: 16704441.00
IBS.LS balance_sheet (annual, 2025-12-31) — Invested Capital: 343017413.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Invested Capital: 343017413.00
IBS.LS cash_flow (annual, 2025-12-31) — Investing Cash Flow: -26471005.00
IBS.LS cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -7574382.00
IBS.LS balance_sheet (annual, 2025-12-31) — Investment Properties: 12238623.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Investment Properties: 12238623.00
IBS.LS balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 1024255.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 1024255.00
IBS.LS cash_flow (annual, 2025-12-31) — Issuance Of Debt: 14499518.00
IBS.LS cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 150642.00
IBS.LS balance_sheet (annual, 2025-12-31) — Land And Improvements: 11644878.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 11644878.00
IBS.LS balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 195000754.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 195000754.00
IBS.LS balance_sheet (annual, 2025-12-31) — Long Term Debt: 20353438.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 20353438.00
IBS.LS balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 215354192.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 215354192.00
IBS.LS cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 14499518.00
IBS.LS cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 150642.00
IBS.LS cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -17565353.00
IBS.LS cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -1387700.00
IBS.LS balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 5441211.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 5441211.00
IBS.LS balance_sheet (annual, 2025-12-31) — Long Term Provisions: 17461.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 17461.00
IBS.LS balance_sheet (annual, 2025-12-31) — Minority Interest: -30938.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Minority Interest: -30938.00
IBS.LS income_statement (annual, 2025-12-31) — Minority Interests: 33052.00
IBS.LS income_statement (quarterly, 2025-12-31) — Minority Interests: -6348.00
IBS.LS cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 0.00
IBS.LS cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -10701715.00
IBS.LS cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -3501567.00
IBS.LS income_statement (annual, 2025-12-31) — Net Income: 15206452.00
IBS.LS income_statement (quarterly, 2025-12-31) — Net Income: 3499389.00
IBS.LS income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 15206452.00
IBS.LS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 3499389.00
IBS.LS income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 15173399.00
IBS.LS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 3505737.00
IBS.LS income_statement (annual, 2025-12-31) — Net Income Discontinuous Operations: 0.00
IBS.LS income_statement (quarterly, 2025-12-31) — Net Income Discontinuous Operations: 0.00
IBS.LS income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 15206452.00
IBS.LS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 3499389.00
IBS.LS income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 15206452.00
IBS.LS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 3499389.00
IBS.LS income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 15173400.00
IBS.LS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 3505738.00
IBS.LS cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -3472475.00
IBS.LS cash_flow (quarterly, 2025-12-31) — Net Intangibles Purchase And Sale: -950935.00
IBS.LS income_statement (annual, 2025-12-31) — Net Interest Income: -14743764.00
IBS.LS income_statement (quarterly, 2025-12-31) — Net Interest Income: -3523878.00
IBS.LS cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 346498.00
IBS.LS cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -2342.00
IBS.LS cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -3065835.00
IBS.LS cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -1237058.00
IBS.LS cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -3065835.00
IBS.LS cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -1237058.00
IBS.LS income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -14743764.00
IBS.LS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -3523878.00
IBS.LS cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 6698000.00
IBS.LS cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 0.00
IBS.LS balance_sheet (annual, 2025-12-31) — Net PPE: 390736428.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Net PPE: 390736428.00
IBS.LS cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -32979311.00
IBS.LS cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -7639564.00
IBS.LS balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 220705716.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 220705716.00
IBS.LS balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 9098759.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 9098759.00
IBS.LS balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 3161362.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 3161362.00
IBS.LS income_statement (annual, 2025-12-31) — Normalized EBITDA: 135088874.00
IBS.LS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 33399918.00
IBS.LS income_statement (annual, 2025-12-31) — Normalized Income: 15618124.00
IBS.LS income_statement (quarterly, 2025-12-31) — Normalized Income: 3463779.40
IBS.LS income_statement (annual, 2025-12-31) — Operating Income: 30827988.00
IBS.LS income_statement (quarterly, 2025-12-31) — Operating Income: 6291232.00
IBS.LS income_statement (annual, 2025-12-31) — Operating Revenue: 529515952.00
IBS.LS income_statement (quarterly, 2025-12-31) — Operating Revenue: 134724043.00
IBS.LS balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 40020861.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 40020861.00
IBS.LS cash_flow (annual, 2025-12-31) — Other Cash Paymentsfrom Operating Activities: -13372907.00
IBS.LS cash_flow (quarterly, 2025-12-31) — Other Cash Paymentsfrom Operating Activities: -1769151.00
IBS.LS balance_sheet (annual, 2025-12-31) — Other Equity Interest: 1.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 1.00
IBS.LS balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 37706046.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 37706046.00
IBS.LS balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 4.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 4.00
IBS.LS income_statement (annual, 2025-12-31) — Other Operating Expenses: 67864616.00
IBS.LS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: -21926391.00
IBS.LS balance_sheet (annual, 2025-12-31) — Other Payable: 14058951.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Other Payable: 14058951.00
IBS.LS balance_sheet (annual, 2025-12-31) — Other Properties: 176074121.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Other Properties: 176074121.00
IBS.LS balance_sheet (annual, 2025-12-31) — Other Receivables: 15015288.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Other Receivables: 15015288.00
IBS.LS balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 328282.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 328282.00
IBS.LS income_statement (annual, 2025-12-31) — Other Special Charges: 577346.00
IBS.LS income_statement (quarterly, 2025-12-31) — Other Special Charges: 72244.00
IBS.LS income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
IBS.LS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
IBS.LS balance_sheet (annual, 2025-12-31) — Payables: 60803436.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Payables: 60803436.00
IBS.LS cash_flow (annual, 2025-12-31) — Paymentson Behalfof Employees: -128423485.00
IBS.LS cash_flow (quarterly, 2025-12-31) — Paymentson Behalfof Employees: -15361025.00
IBS.LS cash_flow (annual, 2025-12-31) — Paymentsto Suppliersfor Goodsand Services: -263614197.00
IBS.LS cash_flow (quarterly, 2025-12-31) — Paymentsto Suppliersfor Goodsand Services: -93640796.00
IBS.LS balance_sheet (annual, 2025-12-31) — Prepaid Assets: 1701959.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 1701959.00
IBS.LS income_statement (annual, 2025-12-31) — Pretax Income: 14796067.00
IBS.LS income_statement (quarterly, 2025-12-31) — Pretax Income: 2695662.00
IBS.LS balance_sheet (annual, 2025-12-31) — Properties: 0.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
IBS.LS cash_flow (annual, 2025-12-31) — Purchase Of Business: 0.00
IBS.LS cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -3472475.00
IBS.LS cash_flow (quarterly, 2025-12-31) — Purchase Of Intangibles: -950935.00
IBS.LS cash_flow (annual, 2025-12-31) — Purchase Of Investment: -33292.00
IBS.LS cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -2219.00
IBS.LS cash_flow (annual, 2025-12-31) — Purchase Of PPE: -32979311.00
IBS.LS cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -7639564.00
IBS.LS balance_sheet (annual, 2025-12-31) — Raw Materials: 15927249.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Raw Materials: 15927249.00
IBS.LS cash_flow (annual, 2025-12-31) — Receiptsfrom Customers: 531155419.00
IBS.LS cash_flow (quarterly, 2025-12-31) — Receiptsfrom Customers: 134668380.00
IBS.LS income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 272083068.00
IBS.LS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 61215342.00
IBS.LS income_statement (annual, 2025-12-31) — Reconciled Depreciation: 102752781.00
IBS.LS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 26392521.00
IBS.LS income_statement (annual, 2025-12-31) — Rent And Landing Fees: 16499959.00
IBS.LS income_statement (annual, 2025-12-31) — Rent Expense Supplemental: 16499959.00
IBS.LS cash_flow (annual, 2025-12-31) — Repayment Of Debt: -17565353.00
IBS.LS cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -1387700.00
IBS.LS cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -10701715.00
IBS.LS cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -3501567.00
IBS.LS balance_sheet (annual, 2025-12-31) — Restricted Cash: 2315128.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 2315128.00
IBS.LS balance_sheet (annual, 2025-12-31) — Retained Earnings: 270224710.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 270224710.00
IBS.LS cash_flow (annual, 2025-12-31) — Sale Of Investment: 379790.00
IBS.LS cash_flow (quarterly, 2025-12-31) — Sale Of Investment: -123.00
IBS.LS cash_flow (annual, 2025-12-31) — Sale Of PPE: 0.00
IBS.LS cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 0.00
IBS.LS income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 15183636.00
IBS.LS income_statement (annual, 2025-12-31) — Selling General And Administration: 22726601.00
IBS.LS balance_sheet (annual, 2025-12-31) — Share Issued: 40899126.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Share Issued: 40899126.00
IBS.LS income_statement (annual, 2025-12-31) — Special Income Charges: -514590.00
IBS.LS income_statement (quarterly, 2025-12-31) — Special Income Charges: 44512.00
IBS.LS balance_sheet (annual, 2025-12-31) — Stockholders Equity: 316999439.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 316999439.00
IBS.LS balance_sheet (annual, 2025-12-31) — Tangible Book Value: 220705716.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 220705716.00
IBS.LS income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -102918.00
IBS.LS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 8902.40
IBS.LS income_statement (annual, 2025-12-31) — Tax Provision: -377332.00
IBS.LS income_statement (quarterly, 2025-12-31) — Tax Provision: -810075.00
IBS.LS income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.20
IBS.LS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.20
IBS.LS balance_sheet (annual, 2025-12-31) — Taxes Receivable: 1297069.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 1297069.00
IBS.LS cash_flow (annual, 2025-12-31) — Taxes Refund Paid Direct: 1212253.00
IBS.LS cash_flow (quarterly, 2025-12-31) — Taxes Refund Paid Direct: -592517.00
IBS.LS balance_sheet (annual, 2025-12-31) — Total Assets: 689395116.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Total Assets: 689395116.00
IBS.LS balance_sheet (annual, 2025-12-31) — Total Capitalization: 337352877.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 337352877.00
IBS.LS balance_sheet (annual, 2025-12-31) — Total Debt: 288395298.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Total Debt: 288395298.00
IBS.LS balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 316968501.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 316968501.00
IBS.LS income_statement (annual, 2025-12-31) — Total Expenses: 498687964.00
IBS.LS income_statement (quarterly, 2025-12-31) — Total Expenses: 128432811.00
IBS.LS balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 372426615.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 372426615.00
IBS.LS balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 525902903.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 525902903.00
IBS.LS balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 218538538.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 218538538.00
IBS.LS income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 29580480.00
IBS.LS income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 6199157.00
IBS.LS income_statement (annual, 2025-12-31) — Total Other Finance Cost: 323408.00
IBS.LS income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: -36291.00
IBS.LS balance_sheet (annual, 2025-12-31) — Total Tax Payable: 36236.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 36236.00
IBS.LS income_statement (annual, 2025-12-31) — Total Unusual Items: -514590.00
IBS.LS income_statement (quarterly, 2025-12-31) — Total Unusual Items: 44512.00
IBS.LS income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -514590.00
IBS.LS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 44512.00
IBS.LS balance_sheet (annual, 2025-12-31) — Tradeand Other Payables Non Current: 5523.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Tradeand Other Payables Non Current: 5523.00
IBS.LS balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 878265.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 878265.00
IBS.LS balance_sheet (annual, 2025-12-31) — Treasury Stock: 8679677.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 8679677.00
IBS.LS balance_sheet (annual, 2025-12-31) — Working Capital: 9604136.00
IBS.LS balance_sheet (quarterly, 2025-12-31) — Working Capital: 9604136.00
IBS.LS income_statement (annual, 2025-12-31) — Write Off: -196000.00
IBS.LS income_statement (quarterly, 2025-12-31) — Write Off: -250000.00
IBS.LS income_statement (quarterly, 2026-03-31) — +Operating Expense: 53444263.00
IBS.LS income_statement (quarterly, 2026-03-31) — +Total Revenue: 121253705.00
IBS.LS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 41074325.00
IBS.LS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 5676503.00
IBS.LS balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -469445632.00
IBS.LS balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 29900789.00
IBS.LS balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -2621478.00
IBS.LS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 140145.00
IBS.LS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 42318717.00
IBS.LS income_statement (quarterly, 2026-03-31) — Basic EPS: -0.06
IBS.LS cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 119859048.00
IBS.LS balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 659723896.00
IBS.LS cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -6307440.00